A Polish legal expert and the German/Canadian President of the European Federation of Pharmaceutical Industries and Associations will be the co-chairs of the next Drug Information Association EuroMeeting.
A Polish legal expert and the German/Canadian President of the European Federation of Pharmaceutical Industries and Associations will be the co-chairs of the next Drug Information Association (DIA) EuroMeeting, to be held in Paris on April 13-15, 2015.
On its web site, DIA has posted brief biographical details about the two co-chairs:
• Lidia Retkowska-Mika, Director, Legal Department, Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Poland. A graduate of the Legal and Administration Department, University of Warsaw, Poland, she has considerable experience in international health issues, especially in collaborative projects with the United States, Canada, and the World Health Organization. Since the accession of Poland to the EU in 2004, she represented Poland as an expert in the Council Working Party on Pharmaceuticals and Medical Devices working on the EU pharmaceutical legislation proposals. She has also participated in the activities of the Heads of Agencies and has been a member of the European Medicines Agencies Cooperation on Legal and Legislative Issues (EMACOLEX).
• Christopher A. Viehbacher, Chief Executive Officer, Sanofi. He is also chairman of Genzyme, which Sanofi acquired in February 2011, and a board member and member of the Strategy Committee. Having worked in finance at PriceWaterhouseCoopers, he joined GlaxoSmithKline (GSK) in 1988, and was President, Pharmaceutical Operations North America. He was elected president of the EFPIA in June 2013, and was chairman of Pharmaceutical Research and Manufacturers of America PhRMA between 2010 and 2012. Since February 2011, he has been chair of the CEO Roundtable on Cancer. He received the French Legion of Honor in 2003 and the 2012 Pasteur Foundation Award, and is a member of International Business Council (WEF) and the Board of Visitors of Fuqua School of Business, Duke University. He is a certified public accountant and a graduate of Queens University (Ontario - Canada), and holds German and Canadian nationalities.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.